Literature DB >> 16877161

External beam radiation helps prevent heterotopic bone formation in patients with a history of heterotopic ossification.

Samuel T Chao1, Shih-Yuan Lee, Lester S Borden, Michael J Joyce, Viktor E Krebs, John H Suh.   

Abstract

The aim of this study was to determine if radiation prevents heterotopic ossification (HO) in HO-forming patients after total hip arthroplasty (THA) or HO excision alone. Patients with HO in the ipsilateral hip (63 treated with THA revision and 25 treated with HO excision alone) and HO in the contralateral hip (36 treated with primary THA) were termed HO-forming patients. They underwent radiation to prevent HO. After excluding patients with inadequate follow-up, 84 patients were studied to determine if radiation prevents significant HO (Brooker Grade 3-4). For patients with ipsilateral hip HO, 12.3% developed significant HO. In patients with contralateral hip HO, 10.5% developed significant HO after THA. Sixty percent who received 6 Gy in 3 fractions after excision of ipsilateral HO developed significant HO, which was higher than for all dose-fractionation schemes combined (P = .01). In contrast, patients who received 7 Gy in 1 fraction developed significant HO 13.8% of the time, which was equivalent to all dose-fractionation schemes combined (P = not significant). Radiation prevents HO in HO-forming patients.

Entities:  

Mesh:

Year:  2006        PMID: 16877161     DOI: 10.1016/j.arth.2005.08.014

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  10 in total

1.  [Heterotopic ossifications in total hip arthroplasty: prophylaxis and therapy].

Authors:  J Schauwecker; F Pohlig; A Toepfer; H Gollwitzer; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2011-06       Impact factor: 1.087

Review 2.  Assessment and management of chronic pain in patients with stable total hip arthroplasty.

Authors:  Tim Classen; Daniela Zaps; Stefan Landgraeber; Xinning Li; Marcus Jäger
Journal:  Int Orthop       Date:  2012-11-23       Impact factor: 3.075

3.  Heterotopic ossification of the elbows in a major petrol burn.

Authors:  Shahriar Raj Zaman
Journal:  BMJ Case Rep       Date:  2012-08-27

Review 4.  Heterotopic ossifications following implant surgery--epidemiology, therapeutical approaches and current concepts.

Authors:  Christian Zeckey; Frank Hildebrand; Michael Frink; Christian Krettek
Journal:  Semin Immunopathol       Date:  2011-01-16       Impact factor: 9.623

Review 5.  Prophylactic Radiotherapy of Hip Heterotopic Ossification: A Narrative Mini Review.

Authors:  Massimiliano De Paolis; Alessio Giuseppe Morganti; Erika Galietta; Luca Gaiani; Claudio Giannini; Andrea Sambri; Milly Buwenge; Gabriella Macchia; Francesco Deodato; Savino Cilla; Lidia Strigari; Michele Fiore; Silvia Cammelli
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

6.  A Case Report about Early Major Postoperative Ossifications of the Shoulder.

Authors:  Maurice Kouame; Moctar Traore; Armand Yepie; Michel Anoumou
Journal:  J Orthop Case Rep       Date:  2016 Sep-Oct

7.  Heterotopic Ossification Encountered During a Complex Ventral Hernia Repair: Case Report and Literature Review.

Authors:  Takintope Akinbiyi; Sanjeev Kaul
Journal:  Eplasty       Date:  2017-09-20

Review 8.  Heterotopic ossification: radiological and pathological review.

Authors:  Bilal Mujtaba; Ahmed Taher; Matthew J Fiala; Sameh Nassar; John E Madewell; Abdelrahman K Hanafy; Rizwan Aslam
Journal:  Radiol Oncol       Date:  2019-09-24       Impact factor: 2.991

Review 9.  Heterotopic ossification in the post cruciate ligament of the knee: a case report and literature review.

Authors:  Cun Li; Zonggui Huang; K C Anil; Chendeng Lao; Qianghua Wu; Hongmian Jiang
Journal:  BMC Musculoskelet Disord       Date:  2021-03-26       Impact factor: 2.362

10.  Prophylaxis of heterotopic ossification - an updated review.

Authors:  Evan O Baird; Qian K Kang
Journal:  J Orthop Surg Res       Date:  2009-04-20       Impact factor: 2.359

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.